Prabhash Kumar Jha, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Altitude | 3 | 2022 | 159 | 1.320 |
Why?
|
| Venous Thrombosis | 4 | 2022 | 1299 | 0.880 |
Why?
|
| Thrombocythemia, Essential | 1 | 2016 | 107 | 0.510 |
Why?
|
| Polycythemia Vera | 1 | 2016 | 160 | 0.490 |
Why?
|
| Blood Coagulation Disorders | 1 | 2018 | 349 | 0.480 |
Why?
|
| Gene Regulatory Networks | 5 | 2024 | 1741 | 0.430 |
Why?
|
| Blood Coagulation | 2 | 2018 | 1157 | 0.420 |
Why?
|
| Gene Expression Profiling | 4 | 2024 | 9411 | 0.380 |
Why?
|
| Myeloproliferative Disorders | 1 | 2016 | 609 | 0.360 |
Why?
|
| Databases, Genetic | 2 | 2021 | 1738 | 0.200 |
Why?
|
| Thymosin | 1 | 2022 | 47 | 0.200 |
Why?
|
| Thrombomodulin | 1 | 2022 | 105 | 0.190 |
Why?
|
| Glucose-6-Phosphatase | 1 | 2021 | 72 | 0.190 |
Why?
|
| MicroRNAs | 3 | 2021 | 3790 | 0.160 |
Why?
|
| Cell Hypoxia | 1 | 2021 | 658 | 0.160 |
Why?
|
| Collagen Type I | 1 | 2022 | 616 | 0.160 |
Why?
|
| Estrogen Receptor alpha | 1 | 2022 | 580 | 0.150 |
Why?
|
| Protein Precursors | 1 | 2022 | 1134 | 0.150 |
Why?
|
| Microarray Analysis | 2 | 2019 | 747 | 0.140 |
Why?
|
| Computational Biology | 3 | 2024 | 3505 | 0.140 |
Why?
|
| Thromboplastin | 1 | 2017 | 286 | 0.130 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2019 | 621 | 0.120 |
Why?
|
| Calcinosis | 1 | 2023 | 1476 | 0.120 |
Why?
|
| Thrombosis | 2 | 2019 | 3052 | 0.110 |
Why?
|
| Heart Valve Diseases | 1 | 2022 | 1047 | 0.110 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2023 | 1518 | 0.100 |
Why?
|
| Neurogenesis | 1 | 2017 | 856 | 0.090 |
Why?
|
| Sleep Deprivation | 1 | 2017 | 840 | 0.090 |
Why?
|
| Aortic Valve Stenosis | 1 | 2023 | 2065 | 0.090 |
Why?
|
| Gene Expression Regulation | 4 | 2024 | 11903 | 0.090 |
Why?
|
| Cells, Cultured | 2 | 2023 | 18957 | 0.080 |
Why?
|
| Microglia | 1 | 2017 | 1351 | 0.080 |
Why?
|
| Endothelial Cells | 1 | 2021 | 3539 | 0.080 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2022 | 4550 | 0.080 |
Why?
|
| DNA Methylation | 1 | 2022 | 4373 | 0.070 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2021 | 17790 | 0.070 |
Why?
|
| Atherosclerosis | 1 | 2023 | 3517 | 0.070 |
Why?
|
| Insulin Resistance | 1 | 2021 | 3959 | 0.070 |
Why?
|
| Gene Expression | 1 | 2019 | 7588 | 0.070 |
Why?
|
| Hippocampus | 1 | 2017 | 3738 | 0.060 |
Why?
|
| Phenotype | 2 | 2021 | 16546 | 0.060 |
Why?
|
| Biology | 1 | 2023 | 290 | 0.050 |
Why?
|
| Rheumatic Heart Disease | 1 | 2022 | 167 | 0.040 |
Why?
|
| Risk Assessment | 2 | 2021 | 24123 | 0.040 |
Why?
|
| Case-Control Studies | 1 | 2018 | 22053 | 0.040 |
Why?
|
| Constriction, Pathologic | 1 | 2023 | 1098 | 0.040 |
Why?
|
| Interferon-beta | 1 | 2021 | 345 | 0.040 |
Why?
|
| Genome-Wide Association Study | 1 | 2018 | 12626 | 0.040 |
Why?
|
| Humans | 11 | 2024 | 760621 | 0.040 |
Why?
|
| Obesity | 1 | 2021 | 12922 | 0.040 |
Why?
|
| Epitopes, T-Lymphocyte | 1 | 2022 | 824 | 0.040 |
Why?
|
| Adult | 3 | 2021 | 219994 | 0.040 |
Why?
|
| Male | 5 | 2024 | 359744 | 0.030 |
Why?
|
| Structure-Activity Relationship | 1 | 2022 | 3084 | 0.030 |
Why?
|
| Maze Learning | 1 | 2017 | 477 | 0.030 |
Why?
|
| Fibrosis | 1 | 2023 | 2042 | 0.030 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2022 | 1355 | 0.030 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2022 | 1827 | 0.030 |
Why?
|
| Disease Susceptibility | 1 | 2022 | 1791 | 0.030 |
Why?
|
| Risk Factors | 2 | 2021 | 74359 | 0.030 |
Why?
|
| Signal Transduction | 3 | 2024 | 23376 | 0.030 |
Why?
|
| Sex Characteristics | 1 | 2024 | 2629 | 0.030 |
Why?
|
| RNA | 1 | 2023 | 2722 | 0.030 |
Why?
|
| Aortic Valve | 1 | 2023 | 1996 | 0.030 |
Why?
|
| Proteome | 1 | 2022 | 1855 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2022 | 5434 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2019 | 2913 | 0.020 |
Why?
|
| Genetic Association Studies | 1 | 2021 | 2717 | 0.020 |
Why?
|
| Rats | 2 | 2017 | 23711 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 2022 | 5785 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2022 | 13451 | 0.020 |
Why?
|
| Overweight | 1 | 2021 | 2421 | 0.020 |
Why?
|
| Protein Binding | 1 | 2022 | 9335 | 0.020 |
Why?
|
| C-Reactive Protein | 1 | 2021 | 3839 | 0.020 |
Why?
|
| Macrophages | 1 | 2023 | 5745 | 0.020 |
Why?
|
| Animals | 4 | 2023 | 167963 | 0.020 |
Why?
|
| Proteomics | 1 | 2022 | 3817 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2017 | 8158 | 0.020 |
Why?
|
| Mice | 2 | 2023 | 81208 | 0.020 |
Why?
|
| Models, Biological | 1 | 2022 | 9467 | 0.020 |
Why?
|
| Venous Thromboembolism | 1 | 2017 | 1864 | 0.010 |
Why?
|
| Cognition Disorders | 1 | 2017 | 3976 | 0.010 |
Why?
|
| Body Mass Index | 1 | 2021 | 12914 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2017 | 18137 | 0.010 |
Why?
|
| Female | 2 | 2024 | 391270 | 0.010 |
Why?
|